Sequent Scientific Balance Sheet Health
Financial Health criteria checks 4/6
Sequent Scientific has a total shareholder equity of ₹6.8B and total debt of ₹4.6B, which brings its debt-to-equity ratio to 67.5%. Its total assets and total liabilities are ₹15.0B and ₹8.2B respectively.
Key information
67.5%
Debt to equity ratio
₹4.61b
Debt
Interest coverage ratio | n/a |
Cash | ₹598.81m |
Equity | ₹6.83b |
Total liabilities | ₹8.18b |
Total assets | ₹15.01b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 512529's short term assets (₹7.7B) exceed its short term liabilities (₹6.0B).
Long Term Liabilities: 512529's short term assets (₹7.7B) exceed its long term liabilities (₹2.2B).
Debt to Equity History and Analysis
Debt Level: 512529's net debt to equity ratio (58.8%) is considered high.
Reducing Debt: 512529's debt to equity ratio has increased from 40% to 67.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 512529 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 512529 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 34.6% per year.